Publications

Abstract AP09: COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA

Authors: G Macintyre, TE Goranova, DD Silva, D Ennis, AM Piskorz, M Eldridge, D Sie,...

E-pub date: 15 Nov 2019

Journal name: Clinical Cancer Research

Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing.

Authors: E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, T...

E-pub date: 14 Nov 2019

Journal name: Cell

CBMT-33. VISUALIZING THE METABOLISM OF GLIOBLASTOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS BY MASS SPECTROMETRY IMAGING

Authors: J Upendra Rao, K Gibson, G Hamm, A Wright, M Fala, R Mair, A Tsyben, R Good...

E-pub date: 11 Nov 2019

Journal name: Neuro-Oncology

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Authors: JM Winfield, JC Wakefield, D Dolling, M Hall, S Freeman, JD Brenton, K Lutc...

E-pub date: 1 Nov 2019

Journal name: Radiology

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

Authors: FC Martins, D-L Couturier, I de Santiago, M Vias, D Sanders, A Piskorz, J H...

E-pub date: 1 Nov 2019

Journal name: Annals of Oncology

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Authors: CF Barbara, C King, M Jimenez-Linan, J Brenton, DS Charnock-Jones

E-pub date: 1 Nov 2019

Journal name: International Journal of Gynecological Cancer

Genetic predisposition to mosaic Y chromosome loss in blood.

Authors: DJ Thompson, G Genovese, J Halvardson, JC Ulirsch, DJ Wright, C Terao, OB D...

E-pub date: 1 Nov 2019

Journal name: Nature

Cellular Senescence: Defining a Path Forward.

Authors: V Gorgoulis, PD Adams, A Alimonti, DC Bennett, O Bischof, C Bishop, J Campi...

E-pub date: 31 Oct 2019

Journal name: Cell

Filters

Research Groups

Core Facilities

Start date

End date

Abstract AP09: COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA

Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing.

CBMT-33. VISUALIZING THE METABOLISM OF GLIOBLASTOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS BY MASS SPECTROMETRY IMAGING

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Genetic predisposition to mosaic Y chromosome loss in blood.

Cellular Senescence: Defining a Path Forward.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Abstract AP09: COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA

Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing.

CBMT-33. VISUALIZING THE METABOLISM OF GLIOBLASTOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS BY MASS SPECTROMETRY IMAGING

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Genetic predisposition to mosaic Y chromosome loss in blood.

Cellular Senescence: Defining a Path Forward.